Normal levels of antithrombin III in acute leukemia complicated by coagulopathy

E Vellenga; NH Mulder

doi:10.1159/000207433

Normal levels of antithrombin III in acute leukemia complicated by coagulopathy

E Vellenga^*, NH Mulder

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

4 Citations (Scopus)

Abstract

A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation studies showed thrombocytopenia, hypofibrinogenemia, high levels of fibrinogen degradation products, a negative protamine test but a normal antithrombin III level. These observations suggest that coagulation abnormalities appearing in acute leukemia are not necessarily due to diffuse intravascular coagulation.

Original language	English
Pages (from-to)	336-338
Number of pages	3
Journal	ACTA HAEMATOLOGICA
Volume	63
Issue number	6
DOIs	https://doi.org/10.1159/000207433
Publication status	Published - 1980

Access to Document

10.1159/000207433

Handle.net

Persistent link

Cite this

@article{45bdb41a6f2041a38849634e5892a797,

title = "Normal levels of antithrombin III in acute leukemia complicated by coagulopathy",

abstract = "A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation studies showed thrombocytopenia, hypofibrinogenemia, high levels of fibrinogen degradation products, a negative protamine test but a normal antithrombin III level. These observations suggest that coagulation abnormalities appearing in acute leukemia are not necessarily due to diffuse intravascular coagulation.",

author = "E Vellenga and NH Mulder",

year = "1980",

doi = "10.1159/000207433",

language = "English",

volume = "63",

pages = "336--338",

journal = "ACTA HAEMATOLOGICA",

issn = "0001-5792",

number = "6",

}

TY - JOUR

T1 - Normal levels of antithrombin III in acute leukemia complicated by coagulopathy

AU - Vellenga, E

AU - Mulder, NH

PY - 1980

Y1 - 1980

N2 - A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation studies showed thrombocytopenia, hypofibrinogenemia, high levels of fibrinogen degradation products, a negative protamine test but a normal antithrombin III level. These observations suggest that coagulation abnormalities appearing in acute leukemia are not necessarily due to diffuse intravascular coagulation.

AB - A patient with acute monoblastic leukemia developed a coagulopathy during chemotherapy. Coagulation studies showed thrombocytopenia, hypofibrinogenemia, high levels of fibrinogen degradation products, a negative protamine test but a normal antithrombin III level. These observations suggest that coagulation abnormalities appearing in acute leukemia are not necessarily due to diffuse intravascular coagulation.

U2 - 10.1159/000207433

DO - 10.1159/000207433

M3 - Comment/Letter to the editor

VL - 63

SP - 336

EP - 338

JO - ACTA HAEMATOLOGICA

JF - ACTA HAEMATOLOGICA

SN - 0001-5792

IS - 6

ER -